First Time Loading...

GNI Group Ltd
TSE:2160

Watchlist Manager
GNI Group Ltd Logo
GNI Group Ltd
TSE:2160
Watchlist
Price: 2 441 JPY 0.37% Market Closed
Updated: May 3, 2024
Section:
 

Relative Value

The Relative Value of one GNI Group Ltd stock under the Base Case scenario is 6 710.67 JPY. Compared to the current market price of 2 441 JPY, GNI Group Ltd is Undervalued by 64%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
6 710.67 JPY
Undervaluation 64%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

4.7
P/S
P/S
Price to Sales
4.7
vs History
68
vs Industry
66
Median 3Y
4.7
Median 5Y
6.2
Industry
8.1
Forward
3
More Details
15
P/E
P/E
Price to Earnings
15
vs History
96
vs Industry
9
Median 3Y
62.5
Median 5Y
79.8
Industry
26.2
Forward
16.9
More Details
18.6
P/OCF
P/OCF
Price to OCF
18.6
vs History
80
vs Industry
9
Median 3Y
41.7
Median 5Y
58.8
Industry
22.6
More Details
16.6
P/FCFE
P/FCFE
Price to FCFE
16.6
vs History
49
vs Industry
8
Median 3Y
-28.4
Median 5Y
16.6
Industry
21.3
More Details
3.6
P/B
P/B
Price to Book Value
3.6
vs History
69
vs Industry
27
Median 3Y
3.6
Median 5Y
4.3
Industry
2.5
More Details
3.9
EV/S
EV/S
Enterprise Value to Sales
3.9
vs History
68
vs Industry
59
Median 3Y
3.9
Median 5Y
5.2
Industry
7.3
Forward
2.5
More Details
4.5
EV/GP
EV/GP
Enterprise Value to Gross Profit
4.5
vs History
68
vs Industry
58
Median 3Y
4.5
Median 5Y
6
Industry
9.1
More Details
17.5
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
17.5
vs History
88
vs Industry
7
Median 3Y
23.3
Median 5Y
31
Industry
4.4
Forward
5.9
More Details
19.6
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
19.6
vs History
88
vs Industry
7
Median 3Y
30.4
Median 5Y
38.8
Industry
4.3
More Details
15.5
EV/OCF
EV/OCF
Enterprise Value to OCF
15.5
vs History
80
vs Industry
10
Median 3Y
36
Median 5Y
51.6
Industry
5.4
More Details
22.7
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
22.7
vs History
58
vs Industry
6
Median 3Y
-26.3
Median 5Y
32.2
Industry
3.2
More Details
2.7
EV/IC
EV/IC
Enterprise Value to IC
2.7
vs History
69
vs Industry
44
Median 3Y
2.9
Median 5Y
3.7
Industry
5
More Details

Multiples Across Competitors

Competitors Multiples
GNI Group Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
JP
GNI Group Ltd
TSE:2160
121.7B JPY 4.7 15 17.5 19.6
US
Abbvie Inc
NYSE:ABBV
284B USD 5.2 58.9 12.8 19.5
US
Amgen Inc
NASDAQ:AMGN
149.1B USD 5.3 22.2 16.5 24.7
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
103.1B USD 10.4 28.5 22.8 23.9
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
102.6B USD 7.8 25.9 17.4 19.1
AU
CSL Ltd
ASX:CSL
133B AUD 6.2 35.4 21.4 26.6
US
Gilead Sciences Inc
NASDAQ:GILD
81.4B USD 3 168.2 6.7 8.8
US
Moderna Inc
NASDAQ:MRNA
48B USD 7 -10.2 -11 -9.4
US
Seagen Inc
NASDAQ:SGEN
43.1B USD 18.8 -57.5 -61.9 -55.8
US
Biogen Inc
NASDAQ:BIIB
31.1B USD 3.2 26.6 13.7 17.1
KR
Celltrion Inc
KRX:068270
38.9T KRW 17.9 72.5 44.4 61.1

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 133,700+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.